Albumin batches and B19 parvovirus DNA

J. J. Lefrere, M. Mariotti, I. De la Croix, J. Lerable, M. Thauvin, T. Burnouf, G. Follea

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: B19 parvovirus (B19) maybe transmitted iatrogenically by blood, and its prevalence in blood donations is estimated at 1 in 3,300 to 1 in 50,000. As a large number of blood donations make up the plasma pools used to produce plasma derivatives, even a virus as rare as B19 in a population of blood donors may result in the frequent contamination of plasma batches. The percentage of albumin batches containing B19 DNA has never been determined. Study Design and Methods: The presence of B19 DNA was investigated by a polymerase chain reaction assay (with a primer pair in the VP1 region) in a total of 12 and 17 batches of 4- and 20-percent albumin, respectively, from two different manufacturers. Results: No B19 DNA was detected in the batches tested. Conclusion: The current fractionation process used to obtain these albumin preparations is seen to allow the efficient degradation and/or elimination of B19.

Original languageEnglish
Pages (from-to)389-391
Number of pages3
JournalTransfusion
Volume35
Issue number5
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Parvovirus
Blood Donors
Albumins
DNA
Viruses
Polymerase Chain Reaction
Population

ASJC Scopus subject areas

  • Immunology
  • Hematology

Cite this

Lefrere, J. J., Mariotti, M., De la Croix, I., Lerable, J., Thauvin, M., Burnouf, T., & Follea, G. (1995). Albumin batches and B19 parvovirus DNA. Transfusion, 35(5), 389-391.

Albumin batches and B19 parvovirus DNA. / Lefrere, J. J.; Mariotti, M.; De la Croix, I.; Lerable, J.; Thauvin, M.; Burnouf, T.; Follea, G.

In: Transfusion, Vol. 35, No. 5, 1995, p. 389-391.

Research output: Contribution to journalArticle

Lefrere, JJ, Mariotti, M, De la Croix, I, Lerable, J, Thauvin, M, Burnouf, T & Follea, G 1995, 'Albumin batches and B19 parvovirus DNA', Transfusion, vol. 35, no. 5, pp. 389-391.
Lefrere JJ, Mariotti M, De la Croix I, Lerable J, Thauvin M, Burnouf T et al. Albumin batches and B19 parvovirus DNA. Transfusion. 1995;35(5):389-391.
Lefrere, J. J. ; Mariotti, M. ; De la Croix, I. ; Lerable, J. ; Thauvin, M. ; Burnouf, T. ; Follea, G. / Albumin batches and B19 parvovirus DNA. In: Transfusion. 1995 ; Vol. 35, No. 5. pp. 389-391.
@article{6b8804b50e0b4d1d90e6abf4f8f335c6,
title = "Albumin batches and B19 parvovirus DNA",
abstract = "Background: B19 parvovirus (B19) maybe transmitted iatrogenically by blood, and its prevalence in blood donations is estimated at 1 in 3,300 to 1 in 50,000. As a large number of blood donations make up the plasma pools used to produce plasma derivatives, even a virus as rare as B19 in a population of blood donors may result in the frequent contamination of plasma batches. The percentage of albumin batches containing B19 DNA has never been determined. Study Design and Methods: The presence of B19 DNA was investigated by a polymerase chain reaction assay (with a primer pair in the VP1 region) in a total of 12 and 17 batches of 4- and 20-percent albumin, respectively, from two different manufacturers. Results: No B19 DNA was detected in the batches tested. Conclusion: The current fractionation process used to obtain these albumin preparations is seen to allow the efficient degradation and/or elimination of B19.",
author = "Lefrere, {J. J.} and M. Mariotti and {De la Croix}, I. and J. Lerable and M. Thauvin and T. Burnouf and G. Follea",
year = "1995",
language = "English",
volume = "35",
pages = "389--391",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Albumin batches and B19 parvovirus DNA

AU - Lefrere, J. J.

AU - Mariotti, M.

AU - De la Croix, I.

AU - Lerable, J.

AU - Thauvin, M.

AU - Burnouf, T.

AU - Follea, G.

PY - 1995

Y1 - 1995

N2 - Background: B19 parvovirus (B19) maybe transmitted iatrogenically by blood, and its prevalence in blood donations is estimated at 1 in 3,300 to 1 in 50,000. As a large number of blood donations make up the plasma pools used to produce plasma derivatives, even a virus as rare as B19 in a population of blood donors may result in the frequent contamination of plasma batches. The percentage of albumin batches containing B19 DNA has never been determined. Study Design and Methods: The presence of B19 DNA was investigated by a polymerase chain reaction assay (with a primer pair in the VP1 region) in a total of 12 and 17 batches of 4- and 20-percent albumin, respectively, from two different manufacturers. Results: No B19 DNA was detected in the batches tested. Conclusion: The current fractionation process used to obtain these albumin preparations is seen to allow the efficient degradation and/or elimination of B19.

AB - Background: B19 parvovirus (B19) maybe transmitted iatrogenically by blood, and its prevalence in blood donations is estimated at 1 in 3,300 to 1 in 50,000. As a large number of blood donations make up the plasma pools used to produce plasma derivatives, even a virus as rare as B19 in a population of blood donors may result in the frequent contamination of plasma batches. The percentage of albumin batches containing B19 DNA has never been determined. Study Design and Methods: The presence of B19 DNA was investigated by a polymerase chain reaction assay (with a primer pair in the VP1 region) in a total of 12 and 17 batches of 4- and 20-percent albumin, respectively, from two different manufacturers. Results: No B19 DNA was detected in the batches tested. Conclusion: The current fractionation process used to obtain these albumin preparations is seen to allow the efficient degradation and/or elimination of B19.

UR - http://www.scopus.com/inward/record.url?scp=0029002859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029002859&partnerID=8YFLogxK

M3 - Article

C2 - 7740609

AN - SCOPUS:0029002859

VL - 35

SP - 389

EP - 391

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 5

ER -